Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LRRK2 | Q5S007 | 18/20 | 0.78 |
| ▸ | KCNH2 | Q12809 | 8/20 | 0.63 |
| ▸ | MARK3 | P27448 | 1/20 | 0.63 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.63 |
| ▸ | BRSK1 | Q8TDC3 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29568377 | 1.00 | LRRK2 (0.78) | LRRK2KCNH2MARK3SCN5ABRSK1 | |
| SCHEMBL29567808 | 1.00 | LRRK2 (0.78) | LRRK2KCNH2MARK3SCN5ABRSK1 | |
| SCHEMBL26965839 | 1.00 | LRRK2 (0.78) | LRRK2KCNH2MARK3SCN5ABRSK1 | |
| SCHEMBL29567756 | 1.00 | LRRK2 (0.78) | LRRK2KCNH2MARK3SCN5ABRSK1 | |
| SCHEMBL29568873 | 0.91 | LRRK2 (0.92) | LRRK2KCNH2MARK3SCN5ABRSK1 | |
| SCHEMBL26965818 | 0.91 | LRRK2 (0.92) | LRRK2KCNH2MARK3SCN5ABRSK1 | |
| SCHEMBL29568374 | 0.91 | LRRK2 (0.92) | LRRK2KCNH2MARK3SCN5ABRSK1 | |
| SCHEMBL29567647 | 0.91 | LRRK2 (0.92) | LRRK2KCNH2MARK3SCN5ABRSK1 | |
| SCHEMBL29568095 | 0.91 | LRRK2 (0.92) | LRRK2KCNH2MARK3SCN5ABRSK1 | |
| SCHEMBL29567691 | 0.90 | LRRK2 (0.65) | LRRK2KCNH2MARK3SCN5ABRSK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4236950-A1 | N-LINKED ISOQUINOLINE AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | Merck Sharp & Dohme LLC (US) | 2023-09-06 | — | — | EP | claimed |
| CN-116390727-A | N-linked isoquinolinamides as LRRK2 inhibitors, pharmaceutical compositions and uses thereof | 默沙东有限责任公司 | 2023-07-04 | — | — | CN | claimed |
| WO-2022093881-A1 | N-LINKED ISOQUINOLINE AMIDES AS LRRK2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF | MERCK SHARP & DOHME CORP. (US) | 2022-05-05 | — | — | WO | claimed |